Prat M, Medico E, Garrino C, Comoglio P M
Department of Biomedical Sciences and Oncology, School of Medicine, University of Turin, Italy.
Int J Cancer. 1989 Jul 15;44(1):67-74. doi: 10.1002/ijc.2910440113.
The monoclonal antibody (MAb) BD-5 reacts with an epitope (CAR-5) expressed in 83% of the gastric carcinomas and in 51% of the ductal pancreatic carcinomas. This MAb reacts also with epithelial cells of colorectal mucosa, but does not react at all with normal adult gastric mucosa or normal adult pancreas. We report the biochemical and immunochemical characterization of CAR-5-bearing molecule. The epitope was found to be carried on a mucin of more than 400 kDa with a density of 1.45 g/ml, metabolically labelled with 35S-sulfate, 3H-glucosamine, 3H-mannose and 35S-methionine. Antigenicity survived metaperiodate oxidation and alkalinization, while it was fully destroyed by pronase or papain. Trypsin, although cleaving the molecule, did not affect its antigenic activity. CAR-5 epitope is thus carried on the protein moiety of a sulfo-mucin. On the basis of its biochemical properties, the antigen was purified by a 3-step procedure, consisting of perchloric acid extraction, molecular sieving on Sepharose CL-4B and affinity chromatography on wheat-germ agglutinin coupled to Sepharose 4B. Cross-competition experiments, together with the chemical properties displayed by the different epitopes, clearly indicate that CAR-5 is different from all previously characterized carcinoma-associated determinants. Cross-DDIRMA experiments performed with different "catcher" and "tracer" antibody combinations showed that CAR-5 epitope may be expressed on the same mucin bearing CA 19-9, MOv2, DU-PAN-2, Lewisa and Lewisb epitopes.
单克隆抗体(MAb)BD - 5与一种表位(CAR - 5)发生反应,该表位在83%的胃癌和51%的胰腺导管癌中表达。这种单克隆抗体也与结直肠黏膜的上皮细胞发生反应,但与正常成人胃黏膜或正常成人胰腺完全不发生反应。我们报告了携带CAR - 5分子的生化和免疫化学特征。发现该表位存在于一种分子量超过400 kDa、密度为1.45 g/ml的粘蛋白上,该粘蛋白用³⁵S - 硫酸盐、³H - 葡糖胺、³H - 甘露糖和³⁵S - 甲硫氨酸进行代谢标记。抗原性在高碘酸盐氧化和碱化后仍能保留,而在链霉蛋白酶或木瓜蛋白酶作用下则完全被破坏。胰蛋白酶虽然能切割该分子,但不影响其抗原活性。因此,CAR - 5表位存在于一种硫粘蛋白的蛋白质部分。基于其生化特性,通过三步程序对抗原进行了纯化,该程序包括高氯酸提取、在琼脂糖CL - 4B上进行分子筛分离以及在与琼脂糖4B偶联的麦胚凝集素上进行亲和层析。交叉竞争实验以及不同表位所显示的化学性质清楚地表明,CAR - 5与所有先前鉴定的癌相关决定簇不同。用不同的“捕获”和“示踪”抗体组合进行的交叉双抗体夹心放射免疫测定实验表明,CAR - 5表位可能在携带CA 19 - 9、MOv2、DU - PAN - 2、Lewis a和Lewis b表位的同一粘蛋白上表达。